Oramed Pharmaceuticals Inc.
ORMPOramed Pharmaceuticals Inc. is a biotech company specializing in the development of oral drug delivery systems for diabetes and other conditions. Its flagship product aims to provide a non-invasive alternative to injectable medications by utilizing innovative oral protein delivery technology. The company focuses on advancing treatments for diabetes and other chronic diseases through its proprietary oral insulin and peptide formulations.
Company News
Oramed Pharmaceuticals announced a Rights Plan to protect against hostile takeovers, distributing one common stock purchase right per outstanding share, with rights becoming exercisable if a person/group acquires 15% or more of outstanding stock.
Penny stocks under $5 to watch this week. The post Best Penny Stocks To Buy Today? 4 To Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The company's lead pipeline candidate is still being evaluated as a potential treatment for NASH after a major flop in treating type 2 diabetes.
